2-Butyl-3-[[2'-cyano-[1,1'-biphenyl]-4-yl]methyl]-1,3-diazaspiro[4,4]non-1-en-4-one
≥97%
- Product Code: 96652
CAS:
138401-24-8
| Molecular Weight: | 385.51 g./mol | Molecular Formula: | C₂₅H₂₇N₃O |
|---|---|---|---|
| EC Number: | MDL Number: | MFCD06658242 | |
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | room temperature, dry |
Product Description:
This compound is primarily utilized in the pharmaceutical industry as an intermediate in the synthesis of active pharmaceutical ingredients (APIs). It plays a crucial role in the development of drugs targeting cardiovascular diseases, particularly hypertension. Its structural features make it a key component in the production of angiotensin II receptor antagonists, which help in managing high blood pressure by blocking the action of angiotensin II, a hormone that constricts blood vessels. Additionally, its unique spirocyclic structure contributes to the stability and bioavailability of the final drug product, enhancing therapeutic efficacy.
Product Specification:
| Test | Specification |
|---|---|
| APPEARANCE | White to Almost white powder to crystal |
| PURITY | 96.5-100 |
| Infrared spectrum | Conforms to Structure |
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.200 | 10-20 days | ฿1,130.00 |
+
-
|
| 1.000 | 10-20 days | ฿3,780.00 |
+
-
|
2-Butyl-3-[[2'-cyano-[1,1'-biphenyl]-4-yl]methyl]-1,3-diazaspiro[4,4]non-1-en-4-one
This compound is primarily utilized in the pharmaceutical industry as an intermediate in the synthesis of active pharmaceutical ingredients (APIs). It plays a crucial role in the development of drugs targeting cardiovascular diseases, particularly hypertension. Its structural features make it a key component in the production of angiotensin II receptor antagonists, which help in managing high blood pressure by blocking the action of angiotensin II, a hormone that constricts blood vessels. Additionally, its unique spirocyclic structure contributes to the stability and bioavailability of the final drug product, enhancing therapeutic efficacy.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :